The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis Dimitrios C. LadakisPavan Bhargava Leading Article 24 January 2023 Pages: 117 - 132
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature Senta FrolMišo ŠabovičJanja Pretnar Oblak Systematic Review 17 January 2023 Pages: 133 - 141
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data Mark Abie HorowitzAdele FramerDavid Taylor Review Article Open access 14 December 2022 Pages: 143 - 157
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation Jules S. MitchellDaniel F. HermensJim Lagopoulos Review Article Open access 22 January 2023 Pages: 159 - 180
Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study Jan LyckeHelen FarmanAnna Nordin Original Research Article Open access 02 February 2023 Pages: 181 - 188
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine Luigi Francesco IannoneDavide FattoriFrancesco De Cesaris Original Research Article 19 January 2023 Pages: 189 - 202